BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27334754)

  • 1. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
    Ghoshal A; Ghosh SS
    Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
    Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
    Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
    Deshmukh A; Kumar S; Arfuso F; Newsholme P; Dharmarajan A
    Sci Rep; 2017 May; 7(1):2256. PubMed ID: 28536422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
    He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
    Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
    Carmon KS; Loose DS
    Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
    Surendran K; Schiavi S; Hruska KA
    J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats.
    Miao CG; Huang C; Huang Y; Yang YY; He X; Zhang L; Lv XW; Jin Y; Li J
    Cell Signal; 2013 Mar; 25(3):598-608. PubMed ID: 23200852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
    Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
    Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG.
    Yasmin IA; Mohana Sundaram S; Banerjee A; Varier L; Dharmarajan A; Warrier S
    Exp Cell Res; 2021 Dec; 409(2):112912. PubMed ID: 34762897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
    Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
    Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of miR-943-3p with secreted frizzled-related proteins4 (SFRP4) in an asthma mouse model.
    Shen J; Zhao J; Ye QY; Gu XD
    Cell Tissue Res; 2019 Oct; 378(1):67-80. PubMed ID: 31101982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
    Perumal V; Dharmarajan AM; Fox SA
    Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction.
    Hewitt DP; Mark PJ; Dharmarajan AM; Waddell BJ
    Biol Reprod; 2006 Jul; 75(1):75-81. PubMed ID: 16540541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
    Sarkar S; Mandal C; Sangwan R; Mandal C
    Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro.
    Longman D; Arfuso F; Viola HM; Hool LC; Dharmarajan AM
    Oncol Res; 2012; 20(1):1-6. PubMed ID: 23035359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
    Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.